Continuous manufacturing is unusual in the world of API manufacture, where the norm is to use batch reactors. Yet, continuous processes are routinely used to make commodity chemicals on a much larger scale. Our experts here at Lonza believe there is great potential to implement more continuous processes when making APIs. Lonza Principal Chemist, Bernhard Gutmann, is giving a webinar that will look at the potential advantages of switching to continuous processing. These include lower costs, higher yields, and more robust processes. He’ll also present a number of case studies that will highlight its versatility in API manufacturing. You can register for the free webinar to learn more about the potential of continuous processing in pharma manufacturing. Date: Wednesday , 25 June Time: 4pm CEST/ 10am EDT. Register: https://lnkd.in/d2MNt42y #ContinuousFlow #Lonza #AdvancedSynthesis #CDMO
Impressive initiative by Lonza. Continuous manufacturing is more than a technical upgrade—it’s a strategic enabler for next-gen pharma operations. From a supply chain perspective, integrating continuous processes into API production supports better end-to-end visibility, leaner inventories, and faster responsiveness across global networks. These are exactly the levers needed to future-proof pharma supply chains in a volatile environment. Sharing insights like this adds real value to the conversation on operational excellence in life sciences. Looking forward to the case studies in the webinar—an important step toward closing the gap between R&D innovation and industrial scalability. #ContinuousFlow #Lonza #AdvancedManufacturing #SupplyChainExcellence #PharmaInnovation #DigitalOperations
OE Project Manager
6dLove this